14 results · 27ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

DIASORIN LIAISON VZV IGG

FDA 510(k)
FDA Class 2 ·Microbiology

Yellowstone

FDA UDI
SUMMIT SPINE LLC·B587X0618200·6mm H x 18mm W x 20mm L x 0 degrees XLIF

Yellowstone

FDA UDI
SUMMIT SPINE LLC·B587X06182080·6mm H x 18mm W x 20mm L x 8 degrees XLIF

Yellowstone

FDA UDI
SUMMIT SPINE LLC·B587L061820120·6mm H x 18mm W x 20mm L XLIF Trial 12 degree Lo...

Yellowstone

FDA UDI
SUMMIT SPINE LLC·B587X061820120·6mm H x 18mm W x 20mm L x 12 degrees XLIF

DENTORIUM CONVERTIBLE ACRYLIC

FDA 510(k)
FDA Class 2 ·Dental

AART SILICONE CARVING BLOCK

FDA 510(k)
FDA Class 2 ·Ear, Nose, Throat

2.0MM NON-COLORED THREADED GUIDE WIRE-SPADE POINT 230MM

FDA Adverse Event
Malfunction ·SYNTHES (USA)·Product code LRN·April 16, 2013

RESTORE ULTRA

FDA Adverse Event
Malfunction ·MEDTRONIC PUERTO RICO OPERATIONS CO., JUNCOS·Product code LGW·March 30, 2011

SOLETRA

FDA Adverse Event
Malfunction ·MEDTRONIC PUERTO RICO OPERATIONS CO.·Product code MHY·June 13, 2008

CANNULA & CATHETER

FDA Adverse Event
Malfunction ·MAQUET CARDIOPULMONARY GMBH·Product code DWF·April 22, 2025

BIOMET StageOne Select, Hip Stem Cement Spacer Mold w/Reinforcement Cement, 13 X 145 MM, Silicone, Sterile, Item 431192.

FDA Enforcement
Class II ·Terminated·Biomet, Inc.·April 15, 2020

CADD¿- Solis Ambulatory Infusion Pump, Model 2111 & 2112, Version 1.0, Version 2.0 and Version 3.0 & Model 2120, Version 1.0. Provide measured drug therapy to patients in hospital or outpatient settings.

FDA Enforcement
Class II ·Terminated·Smiths Medical ASD, Inc.·June 24, 2015

CADD-Solis VIP ambulatory Infusion Pumps, Model 2120 (21-2120, 21-2125, and 21-2127) Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

FDA Enforcement
Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024